Compare Mutual Funds
Tata India Pharma & Healthcare Fund
Select a Mutual Fund
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.37
-
NAV
₹33.46
-
Fund Started
04 Dec 2015
-
Fund Size
₹1565.28 Cr
-
Exit Load
Exit load of 0.25% if redeemed within 30 days.
-
1 Year
8.91%
-
3 Year
18.32%
-
5 Year
13.10%
-
Equity
99.13%
-
Cash
0.87%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.59% |
Divi's Laboratories Ltd. | 6.36% |
Healthcare Global Enterprises Ltd. | 5.85% |
Abbott India Ltd. | 5.63% |
Rainbow Children's Medicare Ltd. | 4.90% |
Glaxosmithkline Pharmaceuticals Ltd. | 4.66% |
Cipla Ltd. | 4.53% |
Dr. Reddy's Laboratories Ltd. | 4.25% |
Max Healthcare Institute Ltd. | 4.07% |
Apollo Hospitals Enterprise Ltd. | 3.90% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
-
Launch Date
04 Dec 2015
-
